Ultracab (India) Share Price
8.84+0.67 (+8.20%)
-10.07% past 1 Year
Corporate filings & documents
Announcements
Enclosed herewith proceedings of the 19th Annual General Meeting of the Company held on September 19 2026.
1 day agoEnclosed herewith proceedings of the 19th Annual General Meeting of the Company held on September 19 2026.
1 day agoPlease find enclosed herewith copies of the newspaper advertisments regarding the circulation of 19th AGM Notice to the Shareholders along with details of e-voting facility.
4 weeks agoPlease find enclosed herewith copies of the newspaper advertisments regarding the circulation of 19th AGM Notice to the Shareholders along with details of e-voting facility.
4 weeks agoPlease find enclosed herewith intimation regarding cut-off date for Evoting for AGM purposes.
1 month agoPlease find enclosed herewith intimation regarding cut-off date for Evoting for AGM purposes.
1 month agoSubmission of 19th Integrated Annual Report for the Financial Year 2025-2026.
1 month agoSubmission of 19th Integrated Annual Report for the Financial Year 2025-2026.
1 month agoPlease find enclosed herewith Notice of the 19th AGM of the Company scheduled to be held on September 19 2026.
1 month agoPlease find enclosed herewith Notice of the 19th AGM of the Company scheduled to be held on September 19 2026.
1 month agoPlease find attached herewith copy of the newspaper publication of public Notice of 19th Annual General Meeting of the Company.
1 month agoPlease find attached herewith copy of the newspaper publication of public Notice of 19th Annual General Meeting of the Company.
1 month agoPlease find enclosed herewith copies of Newspaper publications under Regulation 30 of SEBI Listing Regulations.
1 month agoPlease find enclosed herewith copies of Newspaper publications under Regulation 30 of SEBI Listing Regulations.
1 month agoEnclosed herewith unaudited standalone financial result for the quarter ended on June 30 2026.
1 month agoEnclosed herewith unaudited standalone financial result for the quarter ended on June 30 2026.
1 month agoPlease find enclosed herewith outcome of the Board Meeting held on August 12 2026 under Regulation 30 of the SEBI LODR Regulations 2015.
1 month agoPlease find enclosed herewith outcome of the Board Meeting held on August 12 2026 under Regulation 30 of the SEBI LODR Regulations 2015.
1 month agoUltracab (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Un-audited Standalone Financial Results for the quarter ended on June 30 2026.
1 month agoUltracab (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Un-audited Standalone Financial Results for the quarter ended on June 30 2026.
1 month agoEnclosed herewith intimation under Regulation 30 of SEBI Listing Regulation pursuant to Adjudication order passed by SEBI.
1 month agoEnclosed herewith intimation under Regulation 30 of SEBI Listing Regulation pursuant to Adjudication order passed by SEBI.
1 month agoEnclosed herewith certificate under regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on June 30 2026
2 months agoEnclosed herewith certificate under regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on June 30 2026
2 months agoEnclosed herewith intimation regarding Closure of Trading Window for the quarter ending on June 30 2026 effective from July 01 2026.
3 months agoEnclosed herewith intimation regarding Closure of Trading Window for the quarter ending on June 30 2026 effective from July 01 2026.
3 months agoEnclosed herewith Annual Secretarial Compliance Report for the Financial Year ended March 31 2026.
4 months agoEnclosed herewith intimation regarding newspaper publication of Audited Financial Results for the Fourth quarter ended on March 31 2026.
4 months agoEnclosed herewith are the details of re-appointment of the Tax Auditor of the Company for the FY 2026-27.
4 months agoEnclosed herewith are the details of re-appointment of Internal Auditor of the Company for the FY 2026-27.
4 months agoEnclosed herewith are the details of re-appointment of the Cost Auditor of the Company for the Financial Year 2026-27.
4 months agoEnclosed herewith are the details of re-appointment of the Cost Auditor of the Company for the Financial Year 2026-27.
4 months agoEnclosed herewith Audited Standalone Financial Result for the quarter and financial year ended March 31 2026.
4 months agoEnclosed herewith Audited Standalone Financial Result for the quarter and financial year ended March 31 2026.
4 months agoEnclosed herewith the outcome of the Board meeting held today i.e. Tuesday May 19 2026 under Regulation 30 of the SEBI LODR Regulations 2015.
4 months agoEnclosed herewith the outcome of the Board meeting held today i.e. Tuesday May 19 2026 under Regulation 30 of the SEBI LODR Regulations 2015.
4 months agoUltracab (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve Audited Standalone Financial Results for the quarter and year ended on March 31 2026.
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Ultracab (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L31300GJ2007PLC052394</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>45.94</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB-</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Amit Vishwkarma <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pravin Pansuriya <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 10/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Ultracab (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L31300GJ2007PLC052394</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>45.94</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB-</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Amit Vishwkarma <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pravin Pansuriya <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 10/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months agoPlease find enclosed hereiwith certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026.
5 months agoEnclosed herewith intimation regarding Closure of Trading Window for the quarter ending on March 31 2026 effective from April 01 2026.
6 months agoPlease find attached herewith e-voting results of the postal ballot along with scrutinizers report.
7 months agoPlease find attached herewith outcome of the postal ballot.
7 months agoPlease find enclosed herewith intimation regarding Newspaper publication of financial result for the third quarter ended on December 31 2025.
7 months agoPlease find enclosed herewith unaudited standalone financial results for the quarter and nine month ended on December 31 2025.
7 months agoPlease find attached herewith the outcome of the Board meeting held today i.e. Tuesday February 03 2026 under Regulation 30 of the SEBI LODR Regulations 2015.
7 months agoUltracab (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Un-audited Standalone Financial Results for the quarter and nine months ended on December 31 2025.
7 months agoPlease find enclosed herewith intimation regarding publication of postal ballot Notice in Newspapers.
8 months agoPlease find enclosed herewith Intimation of Postal Ballot Notice along with explanatory Statement seeking approval of members of the Company through electronic voting process (remote- e-voting).
8 months agoPlease find enclosed herewith certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended on December 31 2025.
8 months agoAnnual reports
Concalls & investor presentations
No presentations found